NO172491C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervaterInfo
- Publication number
- NO172491C NO172491C NO890607A NO890607A NO172491C NO 172491 C NO172491 C NO 172491C NO 890607 A NO890607 A NO 890607A NO 890607 A NO890607 A NO 890607A NO 172491 C NO172491 C NO 172491C
- Authority
- NO
- Norway
- Prior art keywords
- alcohic
- dioxane
- preparation
- acid derivatives
- therapeutic active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888803516A GB8803516D0 (en) | 1988-02-16 | 1988-02-16 | Heterocyclic compounds |
GB888824666A GB8824666D0 (en) | 1988-10-21 | 1988-10-21 | Pyridine derivatives |
Publications (4)
Publication Number | Publication Date |
---|---|
NO890607D0 NO890607D0 (no) | 1989-02-13 |
NO890607L NO890607L (no) | 1989-08-17 |
NO172491B NO172491B (no) | 1993-04-19 |
NO172491C true NO172491C (no) | 1993-07-28 |
Family
ID=26293498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO890607A NO172491C (no) | 1988-02-16 | 1989-02-13 | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater |
Country Status (24)
Country | Link |
---|---|
US (1) | US5166213A (no) |
EP (1) | EP0329360B1 (no) |
JP (1) | JP2812697B2 (no) |
KR (1) | KR0145725B1 (no) |
CN (1) | CN1040753C (no) |
AR (1) | AR246965A1 (no) |
AT (1) | ATE109478T1 (no) |
AU (1) | AU626534B2 (no) |
CA (1) | CA1335816C (no) |
DE (1) | DE68917170T2 (no) |
DK (1) | DK66989A (no) |
ES (1) | ES2057104T3 (no) |
FI (1) | FI93216C (no) |
GB (1) | GB8901201D0 (no) |
HU (1) | HU209700B (no) |
IE (1) | IE63825B1 (no) |
IL (1) | IL89214A (no) |
MY (1) | MY103699A (no) |
NO (1) | NO172491C (no) |
NZ (1) | NZ227880A (no) |
PH (1) | PH26227A (no) |
PL (1) | PL158201B1 (no) |
PT (1) | PT89703B (no) |
ZW (1) | ZW1789A1 (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8709794D0 (en) * | 1987-04-24 | 1987-05-28 | Ici Plc | Heterocyclic acids |
IE81170B1 (en) * | 1988-10-21 | 2000-05-31 | Zeneca Ltd | Pyridine derivatives |
GB9021571D0 (en) * | 1990-10-04 | 1990-11-21 | Ici Plc | Heterocyclic acids |
IN2015DN00502A (no) * | 2006-01-18 | 2015-06-26 | Evolva Sa | |
CA2676439A1 (en) * | 2007-01-18 | 2008-07-24 | Evolva Sa | Substituted 1,3-dioxanes and their uses |
EP2124558A4 (en) | 2007-01-18 | 2010-07-14 | Evolva Sa | SUBSTITUTED 1, 3-DIOXANES AND THEIR USE |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0062238B1 (de) * | 1981-03-30 | 1985-01-30 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | 1,3-Dioxolan-Derivate, Herstellung dieser Verbindungen, fungizide Mittel, die diese Verbindungen als Wirkstoffe enthalten sowie Verwendung solcher Verbindungen bzw. Mittel zur Bekämpfung von Fungi in der Landwirtschaft und im Gartenbau |
GB8310407D0 (en) * | 1982-05-12 | 1983-05-25 | Ici Plc | 1 3 - dioxan -5- ylalkenoic acids |
GB8330099D0 (en) * | 1983-11-11 | 1983-12-21 | Ici Plc | Cycloalkane derivatives |
GB8330120D0 (en) * | 1983-11-11 | 1983-12-21 | Ici Plc | Chemical process |
GB8330094D0 (en) * | 1983-11-11 | 1983-12-21 | Ici Plc | Diphenyl compounds |
US4554011A (en) * | 1984-08-24 | 1985-11-19 | Chevron Research Company | Herbicidal 2S-(2β,4β,5β)-5-Arylmethoxy-4-substituted 2-alkyl-1,3-dioxane derivatives |
DK212786A (da) * | 1985-05-10 | 1986-11-11 | Ici Plc | 1,3-dioxanethere |
GB8511894D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Phenol derivatives |
GB8511890D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Benzene derivatives |
GB8511895D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Heterocyclic compounds |
GR861209B (en) * | 1985-05-10 | 1986-08-29 | Ici Plc | Process for preparing novel alkene derivatives |
GB8511892D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Fluoralkane derivatives |
GB8511891D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Alkenoic acids |
GB8611174D0 (en) * | 1986-05-08 | 1986-06-18 | Ici Plc | Amide derivatives |
ES2017633B3 (es) * | 1985-11-12 | 1991-03-01 | Ici Plc | Amido derivados. |
GB8531892D0 (en) * | 1985-12-30 | 1986-02-05 | Ici Plc | Carboxylic acids |
GB8626296D0 (en) * | 1986-11-04 | 1986-12-03 | Ici Plc | Therapeutic agents |
GB8626297D0 (en) * | 1986-11-04 | 1986-12-03 | Ici Plc | Pharmaceutical compositions |
GB8709794D0 (en) * | 1987-04-24 | 1987-05-28 | Ici Plc | Heterocyclic acids |
IE81170B1 (en) * | 1988-10-21 | 2000-05-31 | Zeneca Ltd | Pyridine derivatives |
-
1989
- 1989-01-19 GB GB898901201A patent/GB8901201D0/en active Pending
- 1989-02-07 NZ NZ227880A patent/NZ227880A/xx unknown
- 1989-02-07 IE IE39289A patent/IE63825B1/en not_active IP Right Cessation
- 1989-02-07 IL IL8921489A patent/IL89214A/en not_active IP Right Cessation
- 1989-02-08 CA CA000590484A patent/CA1335816C/en not_active Expired - Fee Related
- 1989-02-13 EP EP89301334A patent/EP0329360B1/en not_active Expired - Lifetime
- 1989-02-13 HU HU89632A patent/HU209700B/hu not_active IP Right Cessation
- 1989-02-13 ZW ZW17/89A patent/ZW1789A1/xx unknown
- 1989-02-13 DE DE68917170T patent/DE68917170T2/de not_active Expired - Fee Related
- 1989-02-13 FI FI890678A patent/FI93216C/fi not_active IP Right Cessation
- 1989-02-13 DK DK066989A patent/DK66989A/da not_active Application Discontinuation
- 1989-02-13 NO NO890607A patent/NO172491C/no unknown
- 1989-02-13 JP JP1031263A patent/JP2812697B2/ja not_active Expired - Lifetime
- 1989-02-13 KR KR1019890001661A patent/KR0145725B1/ko not_active IP Right Cessation
- 1989-02-13 PH PH38187A patent/PH26227A/en unknown
- 1989-02-13 PL PL1989277709A patent/PL158201B1/pl unknown
- 1989-02-13 AU AU29908/89A patent/AU626534B2/en not_active Ceased
- 1989-02-13 PT PT89703A patent/PT89703B/pt active IP Right Grant
- 1989-02-13 ES ES89301334T patent/ES2057104T3/es not_active Expired - Lifetime
- 1989-02-13 CN CN89100858A patent/CN1040753C/zh not_active Expired - Fee Related
- 1989-02-13 AT AT89301334T patent/ATE109478T1/de not_active IP Right Cessation
- 1989-02-14 US US07/310,235 patent/US5166213A/en not_active Expired - Fee Related
- 1989-02-14 AR AR89313211A patent/AR246965A1/es active
- 1989-02-16 MY MYPI89000189A patent/MY103699A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO164025C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater. | |
NO882732L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
NO894630D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater. | |
NO883974L (no) | Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater. | |
NO169900C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive (ih-azol-1-ylmetyl)substituerte benzotriazolderivater | |
NO880182L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater. | |
NO874153D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater. | |
NO161497C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater. | |
NO871295D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
NO893270L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridineddiksyrederivater. | |
NO172575C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzocykloalkanderivater | |
NO171412C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater | |
NO164541C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater. | |
NO870049D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
NO863373D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyre derivater. | |
NO167734C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater. | |
NO891723L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
NO902710L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive r(-) 3-kinuklidinol-derivater. | |
NO891114L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater. | |
NO172491C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater | |
NO874780D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater. | |
NO167801C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater. | |
NO166322C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroapovincaminsyrederivater. | |
NO168825C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-pyrrolidinyltio-1-azabicyklo (3.2.0) hept-2-en-2-karboksylsyrederivater | |
NO890724D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater. |